Dr.Greenberg’s research interests are focused on autoimmune conditions that affect the central nervous system. These include multiple sclerosis, myelitis, neuromyelitis optica spectrum disorder, anti-MOG associated disorder, acute disseminated encephalomyelitis, optic neuritis and autoimmune encephalitis. Dr. Greenberg spends a portion of his research time leading efforts to build a comprehensive biobank of samples from patients with these conditions and the rest of his time leading clinical trial efforts for these conditions. He has a particular focus on phase 1, first in human trials. He has served as the PI for several phase 1 trials and as the IND holder for a first in human gene therapy trial.